companydata.dkcompanydata.dk

ORIFARM PROPERTY A/S: Financial statements 2024

CVR: 27347266

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

ORIFARM PROPERTY A/S (CVR 27347266) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 31,448,000 and a net result of DKK -9,874,000 compared with DKK -7,051,000 the year before. That is an increase of 23.9% compared with the year before. Equity in the 2024 report amounted to DKK 51,786,000. The solvency ratio was 10.4%.

Gross Profit
DKK 31,448,000
Profit/Loss
DKK -9,874,000
Equity
DKK 51,786,000
Total Assets
DKK 498,245,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-31.4M-9.9M51.8M-
2023-25.4M-7.1M61.7M-
2022-21.5M3.5M68.7M0
2021-15.4M7.6M65.2M-
2020-12.3M7.4M72.6M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Mads Fink Eriksen joins the board of ORIFARM PROPERTY A/SOct 1, 2024

As of October 1, 2024, Mads Fink Eriksen has joined the board of directors of ORIFARM PROPERTY A/S.

Jacob Lucassen leaves the board of ORIFARM PROPERTY A/SOct 1, 2024

As of October 1, 2024, Jacob Lucassen has left the board of directors of ORIFARM PROPERTY A/S.

ORIFARM PROPERTY A/S: The 2023 annual report is outJun 10, 2024

ORIFARM PROPERTY A/S has published its annual report for 2023. Gross profit came to DKK 25,387,000, and the net result was DKK -7,051,000.

About ORIFARM PROPERTY A/S

ORIFARM PROPERTY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Udlejning af erhvervsejendomme. The company was previously named EJENDOMSSELSKABET ENERGIVEJ 15 A/S. The management consists of Hans Carl Bøgh-Sørensen. The board consists of Mads Fink Eriksen (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 32,038,000 and a net result of DKK -1,684,000 compared with DKK -9,874,000 the year before. Equity in the 2025 report amounted to DKK 50,102,000.

Source: annual report 2025, Danish Business Authority